ADAR and cancer: Of note, ADAR1 inhibition in cancers may have additional advantages because some tumors depend on ADAR1 and A-to-I(G) editing to escape immune surveillance, potentially enabling anticancer therapies with ADAR1 inhibitors (Rehwinkel and Mehdipour 2025).